Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kelsen

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracilD Kelsen, M Karpeh, G Schwartz, et al.
Current Problems in Surgery|August 1, 1997
Adjuvant therapy for colorectal cancerA M Cohen, D Kelsen, L Saltz, et al.
Oncogene|October 23, 1997
High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomachK Hayashi, R Metzger, D Salonga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeksS Sharma, N Kemeny, G K Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumorsL B Saltz, D Spriggs, L J Schaaf, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 29, 2017
Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs)U Ronellenfitsch, M Schwarzbach, R Hofheinz, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Gastrointestinal Cancer CommitteeC Willett, J Ajani, D Kelsen, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracilD Kelsen, M Karpeh, G Schwartz, et al.
Current Problems in Surgery|August 1, 1997
Adjuvant therapy for colorectal cancerA M Cohen, D Kelsen, L Saltz, et al.
Oncogene|October 23, 1997
High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomachK Hayashi, R Metzger, D Salonga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeksS Sharma, N Kemeny, G K Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumorsL B Saltz, D Spriggs, L J Schaaf, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 29, 2017
Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs)U Ronellenfitsch, M Schwarzbach, R Hofheinz, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Gastrointestinal Cancer CommitteeC Willett, J Ajani, D Kelsen, et al.
Pageof 8